𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

✍ Scribed by Francesco Violi; Domenico Ferro; Stefania Basili; Claudio Quintarelli; Mirella Saliola; Cesare Alessandri; Corrado Cordova; Francesco Balsano


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
597 KB
Volume
15
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Sixty-one patients with different degrees of liver failure, 23 with Child-Pugh class B and 38 with Child-Pugh class C, were studied and observed for 3 yr. Coagulation index analysis showed significantly lower values of prothrombin activity, more prolonged activated partial thromboplastin time, higher bilirubin and fibrinogen degradation products values in class C patients. Among all patients, 28 had fibrinogen degradation products values greater than 10 kg/ml, and in these patients a hyperfibrinolytic state was confirmed by higher values of circulating plasminogen activator antigen (17.3 f 8.7 ng/ml vs. 5.41 f 1.9 ng/ml; p < 0.0001) and activity (6.6 f 2.1 IU/ml vs. 1.92 f 1.12 IU/ml; p < 0.0001) and significantly lower plasminogen activator inhibitor antigen (6.4 f 3.5 ng/ml vs. 15.8 f 5.6 ng/ml; p < 0.0001) and activity (3.6 f 2.2 IU/ml vs. 8.5 2 3.9 IU/ml; p < 0.0001). Patients with positive fibrinogen degradation products had higher serum bilirubin (6 +-4 mg/dl vs. 2 f 2 mg/dl; p < 0.0001) and lower fibrinogen (156 f 52 mg/dl vs. 194 f 62 mg/d& p < 0.02) than patients without hyperfibrinolysis. During the follow-up period, 41 patients died, 22 from fatal gastrointestinal hemorrhage and 19 from liver failure. Thirty patients experienced fatal (22 patients) and nonfatal (8 patients) gastrointestinal hemorrhage. Patients with positive fibrinogen degradation products or class C had a higher risk of gastrointestinal bleeding than patients with negative fibrinogen degradation products (odds ratio = 8) or class B (odds ratio = 3.5), respectively. Cox's multiple regression model showed that positive fibrinogen degradation products was the best bleeding predictor (p coefficient = 3.9 f 0.7 S.E.M., p < 0.001).

This study indicates that in cirrhosis the presence of hyperfibrinolysis should be regarded as an important warning sign of gastrointestinal bleeding. (HEPA- TOLOGY 1992;15:672-676.)


πŸ“œ SIMILAR VOLUMES


Hyperfibrinolysis Resulting from Clottin
✍ Francesco Violi; Domenico Ferro; Claudio Quintarelli; Antonio Musca; Francesco B πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 628 KB

This study explored the relationship between clotting activation and tissue plasminogen activator and its inhibitor in cirrhotic patients with different degrees of liver failure. Sixty-seven patients (40 men, 27 women; age = 31-77 yr) with cirrhosis diagnosed by liver biopsy were divided into three

Systemic antibiotic prophylaxis after ga
✍ A Pauwels; N Mostefa-Kara; B Debenes; E Degoutte; V Levy πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 1 views

of the bleeding. In patients with serum creatinine level ΓΊ200 mmol/ L, doses were reduced to amoxicillin plus clavulanic acid (Augmentin, Beecham, Nanterre, France) 500 mg/100 kg twice daily and ciproflox-From the Unite Β΄de Soins Intensifs, Service d'He Β΄pato-Gastroente Β΄rologie, Ho Λ†pital Saintacin

Beta-adrenergic antagonists in the preve
✍ B. Bernard; D. Lebrec; P. Mathurin; P. Opolon; T. Poynard πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 2 views

of beta-blockers in the prevention of recurrent bleeding in A meta-analysis of 12 selected randomized trials was patients with cirrhosis and to assess the effect of this drug performed to assess the efficacy of beta-blockers in the on long-term survival by a new meta-analysis, including reprevention